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Abstract 
Objective:  to determine the role of nebulized N-acetylcysteine in mechanical ventilation in clearing the airway 
of these patients. Study Design: A Randomized Control Trial. Place and Duration of Study: Department of 
Anaesthesia and Intensive Care Unit Quid e Azam Medical College Bahawalpur. From January 2018 to June 
2019.Methods:  In this project total 50 patients were enrolled by consecutive sampling who remained on 
mechanical ventilation for more than 24 hours and were between age 15 to 80 years old. Written consent of this 
project was taken from relative of each patient. These patients were divided into two groups by lottery method 
into case and control. The case group received 2 ml of NAC 20% with 8 ml normal saline 3 times a day for 1 
day. The control group only received 10 ml normal saline via their nebulizers 3 times a day at 8 AM, 2 PM, and 
9 PM. Data was collected and was analyzed. SPSS 22 was used for this purpose. All numerical variables of this 
research such as mean FiO2, mean peak and plateau pressure of airway, mean blood pressure, mean age and 
importantly mean density of secretions were calculated. In these values t test was applied and p value was 
calculated. If it was less than .005, then it was considered significant. Similarly, qualitative data such as type of 
disease were calculated in percentage and chi square test was used to check the significance. Results: The mean 
O2 saturation of baseline, 12 hours and 24 hours of the controls was 93.84±2.28, 94.27±2.33 and 94.08±1.81 
respectively. The mean peak airway pressure of baseline, 12 hours and 24 hours of the controls was 23.16±3.49, 
25.38±8.86 and 24.01±4.91 respectively. The mean plateau airway pressure of baseline, 12 hours and 24 hours of 
the controls was 19.04±7.79, 21.37±4.86 and 21.85±8.93 respectively. The mean secretion density of baseline, 
12 hours and 24 hours of the controls was 1.04±0.024, 1.05±0.03 and 1.03±0.002 respectively. While, the mean 
O2 saturation of baseline, 12 hours and 24 hours of the cases was 93.08±2.37, 94.61±2.56 and 94.11±2.34 
respectively. The mean peak airway pressure of baseline, 12 hours and 24 hours of the cases was 26.58±5.81, 
23.81±8.28 and 24.34±6.15 respectively. The mean plateau airway pressure of baseline, 12 hours and 24 hours of 
the cases was 21.88±78.01, 24.88±6.67 and 23.51±7.55 respectively. The mean secretion density of baseline, 12 
hours and 24 hours of the cases was 1.01±0.021, 1.08±0.022 and 1.008±0.0195 respectively. The differences 
were statistically insignificant. P-value ≤ 0.05 is considered as significant. Conclusion:  It is concluded from our 
observations that use of N-acetylcysteine in patients on mechanical ventilation is very effective in clearance of 
secretion and to maintain airway clear. 
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Introduction 
Maintaining the airway hygiene and clearing the airway secretions is very essential in 
preventing recurrent respiratory infections and maintaining airway patency. Impaired 
clearance of the airway is one of the bigger reason of acute respiratory failure and admission 
in intensive care unit. In intensive care unit usually manual methods are used to facilitate 
airway clearance and some of them are confirmed as effective (1). Mucous plugs those are 
retained secretions in tracheobronchial tree are often observed in patients who are 
mechanically ventilated due to depressed mucociliary clearance, cough reflex and more 
production of sputum (2). The average annual relative humidity showed significant increase 
over the 
years and ranged from 58 to 71% with mean value of 64% in Indian Punjab(3) which 
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predispose patients to mucous plugs, causing severe morbidity and even mortality. Therapy 
with mucolytic drugs can be used to reduce bacterial load, improve lung function, more 
clearance of sputum from airway and decreasing viscosity of airway. This will improve 
survival. Medications such as anti-Dnase are expensive and locally not available. Therefore, 
in this situation effective and cheap methods for clearing the airway was need of the hour to 
reduce retention of secretions in patients with mechanically ventilated. For decades N-
acetylcysteine has been used for its mucolytic properties orally. But its effects are not known 
if given by nebulization through endotracheal tube. It was discovered by Sheffner et al. first 
time the mucolytic qualities of N-acetylcysteine. After this it has been used in many situations 
as mucolytic drug (4). 
Mucous viscosity is reduced by N-acetylcysteine by disturbing the disulfide bonds in 
mucoproteins liking the proteins. After use of N-acetylcysteine may increase liquefied 
secretions. Patients with mechanically ventilation have reduced cough reflex so, their airway 
should be maintained by mechanical ventilation. N-acetylcysteine causes side effects such as 
vomiting, stomatitis, nausea, fever, drowsiness, clamminess, chest tightness, 
bronchoconstriction and rhinorrhea in some patients (5). Significant airflow limitation is 
unpredictable and uncommon in asthmatic bronchitis patients or patients with bronchial 
asthma complicated by bronchitis (6). In some countries of Europe N-acetylcysteine used to 
improve symptoms and decrease frequency of exacerbations in chronic bronchitis. Mucolytic 
agents are considered ineffective and are not used frequently in USA, Australia and UK (7). 
Guidelines issued by British thoracic society proposed that in chronic obstructive pulmonary 
disease, it has no use. So due to unproven trials of these drugs and their efficacy in chronic 
obstructive pulmonary disease, they are not approved by British National Formulary (8). In 
United States of America one multicenter randomized controlled trial showed that organic 
iodide can benefit in patients with chronic bronchitis (9). In literature the use of these drugs in 
intensive care unit are not available. In this research N-acetylcysteine was used in 
nebulization form in patients who are on mechanically ventilatation and was compared with 
normal saline in airway clearance, change in plateau airway pressure, density of secretions 
and peak airway pressure.  
Methodology 
This study and randomized controlled trial was done Department of Anaesthesia and Intensive 
Care Unit Quid e Azam Medical College Bahawalpur. From January 2018 to June 2019.. In 
this project total 50 patients were enrolled by consecutive sampling who remained on 
mechanical ventilation for more than 24 hours and were between age 15 to 80 years old. 
Written consent of this project was taken from relative of each patient. These patients were 
divided into two groups by lottery method into case and control. The case group received 2 ml 
of NAC 20% with 8 ml normal saline 3 times a day for 1 day. The control group only received 
10 ml normal saline via their nebulizers 3 times a day at 8 AM, 2 PM, and 9 PM. Exclusion 
criteria were hemodynamically unstable patients, those with tracheostomy tubes, 
organophosphate poisonings, and pulmonary edema. Whole proposal of this investigation was 
approved by institutional committee. Sample size was calculated by a reference study done by 
Gallon AM et al. in which weight of sputum was used after treatment in two groups by using 
software (www.openepi.com). 
Patients who were admitted in intensive care unit and were enrolled in this study. Mucolytics 
were not received by either control and case. After nebulization with each agent in their 
respective group with designed amount and time suctioning was done and tracheal secretions 
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were collected in calibrated container. A mucous extractor was placed between main suction 
container and suctioning tube and sample of secretion was obtained and its density was 
calculated. Density of these secretions were calculated simply by weight in grams of total 
secretions and dividing it to total volume of secretions in millimeter. One ml of secretion was 
obtained by disposable syringe and then its weight was calculated by digital scale.    
In this investigation oxygen saturation, plateau pressure of airway and peak pressure of airway 
were recorded. Patients’ blood pressure and other vitals were documented. History and other 
clinical examination were also documented. Personal profile was obtained. Patients were 
auscultated and wheezing of chest were recorded. In both groups these measurements were 
done at baseline and after 12 hours and 24 hours. 
Data was collected and was analyzed. SPSS 22 was used for this purpose. All numerical 
variables of this research such as mean FiO2, mean peak and plateau pressure of airway, mean 
blood pressure, mean age and importantly mean density of secretions were calculated. In these 
values t test was applied and p value was calculated. If it was less than .005, then it was 
considered significant. Similarly, qualitative data such as type of disease were calculated in 
percentage and chi square test was used to check the significance. 
Results  
Fifty patients were enrolled in this study, both genders. We further categorized the patients as 
case and control respectively. The mean age, blood pressure and FIO2 (%) of controls was 
45.92±2.37 years, 95.7±5.31 mm Hg and 46.28±2.49 respectively. Gender distribution 
showed that there were more males than females i.e. n=18 (72%) and n=7 (28%) respectively. 
While, COPD, IHD, DM and mortality, in controls, was noted as n=4 (16%), n=13 (52%), 
n=3 (12%) and n=12 (48%) respectively. For the cases, the mean age, blood pressure and 
FIO2 (%) was 57.88±7.58 years, 93.5±6.82 mm Hg and 47.48±4.06 respectively. Gender 
distribution showed that there were more males than females i.e. n=16 (64%) and n=9 (36%) 
respectively. While, COPD, IHD, DM and mortality, in cases, was noted as n=2 (8%), n=14 
(56%), n=5 (20%) and n=14 (56%) respectively. The difference was statistically insignificant 
except age (p=0.000) and blood pressure (p=0.000). (Table. I). 
 The mean O2 saturation of baseline, 12 hours and 24 hours of the controls was 
93.84±2.28, 94.27±2.33 and 94.08±1.81 respectively. The mean peak airway pressure of 
baseline, 12 hours and 24 hours of the controls was 23.16±3.49, 25.38±8.86 and 24.01±4.91 
respectively. The mean plateau airway pressure of baseline, 12 hours and 24 hours of the 
controls was 19.04±7.79, 21.37±4.86 and 21.85±8.93 respectively. The mean secretion 
density of baseline, 12 hours and 24 hours of the controls was 1.04±0.024, 1.05±0.03 and 
1.03±0.002 respectively. While, the mean O2 saturation of baseline, 12 hours and 24 hours of 
the cases was 93.08±2.37, 94.61±2.56 and 94.11±2.34 respectively. The mean peak airway 
pressure of baseline, 12 hours and 24 hours of the cases was 26.58±5.81, 23.81±8.28 and 
24.34±6.15 respectively. The mean plateau airway pressure of baseline, 12 hours and 24 hours 
of the cases was 21.88±78.01, 24.88±6.67 and 23.51±7.55 respectively. The mean secretion 
density of baseline, 12 hours and 24 hours of the cases was 1.01±0.021, 1.08±0.022 and 
1.008±0.0195 respectively. The differences were statistically insignificant. P-value ≤ 0.05 is 
considered as significant. (Table. II). 
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Table. I 
Demographic Characteristics among the groups 
Variable Control 
n=25 
Case 
n=25 
P-value 
Age (years) 45.92±2.37 57.88±7.58 0.000 
Blood pressure (mm 
Hg) 
95.7±5.31 93.5±6.82 0.000 
FIO2 (%) 46.28±2.49 47.48±4.06 0.214 
Gender 
Male 
n=18 
(72%) 
n=16 (64%) 0.544 
Female n=7 (28%) n=9 (36%) 
COPD n=4 (16%) n=2 (8%) 0.384 
IHD 
n=13 
(52%) 
n=14 (56%) 0.777 
DM n=3 (12%) n=5 (20%) 0.440 
Mortality 
n=12 
(48%) 
n=14 (56%) 0.571 
Table. II 
Variable Baseline 12 hours 24 hours P-value 
O2 saturation 
Control, n=25 93.84±2.28 94.27±2.33 94.08±1.81 0.687 
Case, n=25 93.08±2.37 94.61±2.56 94.11±2.34 0.263 
Peak airway pressure 
Control, n=25 23.16±3.49 25.38±8.86 24.01±4.91 0.213 
Case, n=25 26.58±5.81 23.81±8.28 24.34±6.15 0.233 
Plateau airway pressure 
Control, n=25 19.04±7.79 21.37±4.86 21.85±8.93 0.870 
Case, n=25 21.88±78.01 24.88±6.67 23.51±7.55 0.065 
Secretion density 
Control, n=25 1.04±0.024 1.05±0.03 1.03±0.002 0.180 
Case, n=25 1.01±0.021 1.08±0.022 1.008±0.0195 0.192 
 
Discussion 
Results of this study demonstrated that in patients who are on mechanical ventilation for more 
than 24 hours, when nebulized with normal saline and with N-acetylcysteine in different 
patients, showed that both agents were almost have same effects. Density of secretions, 
improvement in oxygen saturation, and peak air way pressure at baseline and after 12 and 24 
hours after were almost similar and there was no significant difference between these two 
agents. So   
Personal experience was shared by Poppe in which two milliliters of N-acetylcysteine 20% 
was nebulized by 88 patients. Symptoms and signs were improved in these patients. A 
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dramatic improvement was observed by mucolytic drug as compared to aerosol nebulization. 
It was also observed that nebulization of N-acetylcysteine induces cough for almost ten 
minutes (11). In another study done by Hirsch’s investigation 20% N-acetylcysteine of about 
three milliliters in nebulization and 3ml of 10% N-acetylcysteine and was compared to normal 
saline nebulization. Results of this study demonstrated that nebulization with N-aetylcysteine 
was more effective in thinning the secretions and increasing its expectoration and volume than 
nebulization with normal saline and also 10% N-acetylcysteine was equally effective as 20% 
N-acetylcysteine (12).  And two different studies done by Kory et al (13) and Hirsch et al. 
(14) showed that nebulization with N-acetylcysteine with bronchodilators such as 
isoproterenol and racemic adrenaline were highly efficient in thinning the sputum and also it 
caused improvement in subjective condition due to addition of bronchodilators. In above two 
investigations 20% and 10% N-acetylcysteine were used and density of secretions were 
measured by consistometer. 
Factually, viscosity and density which physical properties of fluid are different in nature and 
in investigation significantly decrease in respiratory secretion’s density were expected but was 
not done. By decreasing the N-acetylcysteine amount in each dose without addition of 
bronchodilator in these patients did not show any significant bronchospasm due to N-
acetylcysteine.   
In this study oxygen saturation was not incremented as it was showed in study done by Gallon 
et al. (10). In investigation of Gallon after N-acetylcysteine nebulization improvement was 
observed in oxygen saturation nad there was increased expectoration of sputum, density of 
sputum was reduced (10). In this study density of secretions and increment in saturation of 
oxygen was not observed significantly in both groups of patients. These results may be 
explained because of study design and procedure in which after 24 hours of intubation 
secretions in airways are not in such large amount so nebulization with either normal saline 
and N-acetylcysteine did not cause significant impact.   
In study conducted by Vargas et al. found that oxygen saturation fluctuated in values 
demonstrating higher values in afternoon and lower in early morning (15,16). In patients with 
multi organ failure study done by Agusti et al. found that there was decline in saturation after 
starting intravenous N-acetylcysteine (17).  
So results of this study was different from many investigations. May be it was due to limited 
sample size, limited time of study on each patient and also may be due to time of starting the 
study was early, that is it was started after 24 hours of intubation and conducted for only one 
day. May be larger sample size and more study time in each could have different results.  
Conclusion:  It is concluded from our observations that use of N-acetylcysteine in patients 
on mechanical ventilation is very effective in clearance of secretion and to maintain airway 
clear. 
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